Voors AA, Angermann CE, Teerlink JR, Collins SP, Kosiborod M, Biegus J, Ferreira JP, Nassif ME, Psotka MA, Tromp J, Borleffs CJW, Ma C, Comin-Colet J, Fu M, Janssens SP, Kiss RG, Mentz RJ, Sakata Y, Schirmer H, Schou M, Schulze PC, Spinarova L, Volterrani M, Wranicz JK, Zeymer U, Zieroth S, Brueckmann M, Blatchford JP, Salsali A, Ponikowski P
GLP1 or E monotherapies in an obese model of PCOS Since the 10 nmol/kg dose of GLP1/E was at least as effective as higher doses in improving the metabolic profile of PCOS mice, we compared its beneficial effects in terms of body weight, fat mass, glucose tolerance, insulin sensitivity, and other traits vs
They examined caloric intake during an open-ended meal as well as participant-reported appetite ratings and Control of Eating Questionnaire (CoEQ) responses
Intramuscular NAD+ injections (administered into the muscle) offer faster onset, useful for patients who want quicker effects between doses
Graciela Scharovsky, Lilian I
